Table of Contents
Chapter 1. Global Toxicology Drug Screening Market Executive Summary
1.1. Global Toxicology Drug Screening Market Size & Forecast (2024-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product Type
1.3.2. By Test Type
1.3.3. By Technology Type
1.3.4. By End Users
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Toxicology Drug Screening Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Toxicology Drug Screening Market Dynamics
3.1. Market Drivers
3.1.1. Rising Prevalence of Drug Abuse
3.1.2. Stricter Laws and Regulations
3.1.3. Advancements in Analytical Technologies
3.2. Market Challenges
3.2.1. High Cost of Screening Technologies
3.2.2. Regulatory Hurdles
3.3. Market Opportunities
3.3.1. Integration of Advanced Technologies
3.3.2. Expansion in Emerging Markets
Chapter 4. Global Toxicology Drug Screening Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Toxicology Drug Screening Market Size & Forecasts by Product Type 2024-2032
5.1. Segment Dashboard
5.2. Global Toxicology Drug Screening Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Monitoring and Logging
5.2.2. Security
5.2.3. Storage and Continuous Integration/Continuous Deployment
5.2.4. Management and Orchestration
5.2.5. Networking and Data Management Services
5.2.6. Others
Chapter 6. Global Toxicology Drug Screening Market Size & Forecasts by Test Type 2024-2032
6.1. Segment Dashboard
6.2. Global Toxicology Drug Screening Market: Test Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Acute Systemic Toxicity
6.2.2. Dermal Toxicity
6.2.3. Carcinogenicity
6.2.4. Ocular Toxicity
6.2.5. Genotoxicity
6.2.6. Neurotoxicity
6.2.7. Organ-Specific Toxicity
Chapter 7. Global Toxicology Drug Screening Market Size & Forecasts by Technology Type 2024-2032
7.1. Segment Dashboard
7.2. Global Toxicology Drug Screening Market: Technology Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. High-Throughput Screening
7.2.2. Genomics
7.2.3. Transcriptomics
7.2.4. Toxicogenomics
7.2.5. Molecular Screening
Chapter 8. Global Toxicology Drug Screening Market Size & Forecasts by End Users 2024-2032
8.1. Segment Dashboard
8.2. Global Toxicology Drug Screening Market: End Users Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Hospitals and Trauma Centers
8.2.2. Forensic Laboratories
8.2.3. Diagnostic Laboratories
8.2.4. Rehabilitation Centers
8.2.5. Pharmaceutical & Biotechnology Companies
Chapter 9. Global Toxicology Drug Screening Market Size & Forecasts by Region 2024-2032
9.1. North America Toxicology Drug Screening Market
9.1.1. U.S. Toxicology Drug Screening Market
9.1.1.1. Product Type breakdown size & forecasts, 2024-2032
9.1.1.2. Test Type breakdown size & forecasts, 2024-2032
9.1.1.3. Technology Type breakdown size & forecasts, 2024-2032
9.1.1.4. End Users breakdown size & forecasts, 2024-2032
9.1.2. Canada Toxicology Drug Screening Market
9.2. Europe Toxicology Drug Screening Market
9.2.1. U.K. Toxicology Drug Screening Market
9.2.2. Germany Toxicology Drug Screening Market
9.2.3. France Toxicology Drug Screening Market
9.2.4. Spain Toxicology Drug Screening Market
9.2.5. Italy Toxicology Drug Screening Market
9.2.6. Rest of Europe Toxicology Drug Screening Market
9.3. Asia-Pacific Toxicology Drug Screening Market
9.3.1. China Toxicology Drug Screening Market
9.3.2. India Toxicology Drug Screening Market
9.3.3. Japan Toxicology Drug Screening Market
9.3.4. Australia Toxicology Drug Screening Market
9.3.5. South Korea Toxicology Drug Screening Market
9.3.6. Rest of Asia-Pacific Toxicology Drug Screening Market
9.4. Latin America Toxicology Drug Screening Market
9.4.1. Brazil Toxicology Drug Screening Market
9.4.2. Mexico Toxicology Drug Screening Market
9.4.3. Rest of Latin America Toxicology Drug Screening Market
9.5. Middle East & Africa Toxicology Drug Screening Market
9.5.1. Saudi Arabia Toxicology Drug Screening Market
9.5.2. South Africa Toxicology Drug Screening Market
9.5.3. Rest of Middle East & Africa Toxicology Drug Screening Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Agilent Technologies, Inc.
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Covance, Inc.
10.3.3. Bio-Rad Laboratories, Inc.
10.3.4. BioReliance, Inc.
10.3.5. Thermo Fisher Scientific, Inc.
10.3.6. Eurofins Scientific SE
10.3.7. GE Healthcare
10.3.8. General Electric Company
10.3.9. Quest Diagnostics
10.3.10. Alere, Inc.
10.3.11. Enzo Life Sciences, Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes